The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.
The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
Last, the administration's proposal also tries to shore up guardrails for the use of AI in health care with edits to existing ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...
West Virginia Gov. and Senator-elect Jim Justice said Tuesday he supports a plan by President Joe Biden’s administration to expand access to costly weight-loss drugs like Ozempic and Wegovy, but ...